Entertainment - Dubai Global Village Season 31 Opens on October 14 with Drone S… Weather - Hail Hits Sharjah as Lightning and Runoff Captured on Video; Mo… Update - Dubai Has Nearly Dh2.1 Trillion in Active Projects Underway, Sa…

Send an Inquiry

Fill in the details below and our team will get back to you.

Business 1 min read 19 views

Julphar Reports First Six Months Earnings

Julphar, the largest generic pharmaceutical manufacturer in Middle East and North Africa (MENA), introduced sales revenue of AED 639 million in the very first semester of the year 2017. The company uploaded a web earnings of AED 64 million.

Julphar's Chairman, His Highness Sheikh Faisal Bin Saqr Al Qasimi, stated: "Julphar is now moving forward in the direction of accomplishing its objectives for 2020 to remain at the top of the regional market. We are extremely pleased with the success we have achieved considering that the start of the year. Dandasha has been introduced throughout Q1. 17 in the UAE to deal with erectile disorder in adult men and by Q2, it has actually become a leader in its segment. And ourfront runner item MEBO is still leading the Saudi market. Furthermore - the company has kept its leading placement in the UAE by attaining a robust double figure growth in Q2.17.".

" I expect those achievements to benefit the company during the second semester of the year, and to additionally grow earnings and earnings. Particularly as we are dedicated to boost our working capital, continue our efficiency initiatives and cost saving efforts. Despite the difficult problems affecting the pharmaceutical market in Saudi Arabia and currency headwinds in Egypt, great outcomes were really accomplished in the region, where market has actually shown indicators of enhancement during the 2nd quarter. With 34 brand-new products signed up in H1.17, this gives us needs to be confident for the future," he included.

About Julphar.
Established in 1980, Julphar is the biggest generic pharmaceutical producer in Middle East and North Africa, generating over 200 top quality products throughout 16 facilities. Julphar's goal is to provide top quality medicines at inexpensive rates. Our product profile includes Biotechnology, Wound and Women Care, Adult and Pediatric General Medicines,.

Gastro and Pain Management, Cardio-Metabolism, Diabetic issues Solutions and Customer variety. Julphar employs more than 3,000 people around the world and signed up income of AED 1.45 billion in 2016. For additional information, please visit http://www.julphar.net.

Related News

More on Business

View all

Comments (0)

Join the conversation

No comments yet. Be the first to share your thoughts!

More News

See all
Environment

Majra Hosts Impact Investment Lab at Investopia Bridge 2026 to Mobilise Sustainable Capital

Majra – National CSR Fund has convened an Impact Investment Lab at the fifth edition of Investopia Bridge 2026, bringing together key stakeholders to identify practical ways to channel capital towards investments delivering measurable economic, social and environmental impact in the UAE. The...

Oct 14, 2026 · 2 min
Real Estate

Kasumigaseki Properties Development Brings Japanese Real Estate Philosophy to UAE

Tokyo-listed Kasumigaseki Capital Co., Ltd. is expanding its presence in the United Arab Emirates from real estate investment into property development through its development arm, Kasumigaseki Properties Development, introducing a Japanese approach centred on quality, peace of mind and...

Oct 14, 2026 · 3 min
Real Estate

BI Group Signs MOU with CITIC for Three Dubai Developments in Meydan Horizon

BI Group has signed a Memorandum of Understanding (MOU) with CITIC Middle East Contracting LLC, the UAE subsidiary of China’s CITIC Construction Co., Ltd., to collaborate on three upcoming real estate developments in Dubai’s Meydan Horizon district. The agreement establishes a...

Oct 14, 2026 · 2 min
Real Estate

Saudi Real Estate Refinance Company Launches First Credit-Rated RMBS Issuance

The Saudi Real Estate Refinance Company (SRC), a Public Investment Fund (PIF) company, has launched its second residential mortgage-backed securities (RMBS) issuance, becoming the first domestic issuance of its kind in Saudi Arabia to receive published credit ratings from Moody’s Ratings and...

Oct 14, 2026 · 3 min

Our Associates


Add Business Card Add Event Add Directory Add Forum